| |
Units
|
Attack, all, first LP/event
|
Remission, all, last LP/event
|
p values
|
|---|
|
Pleocytosis
|
Samples
|
54/102 (52.9%)
|
2/20 (10%)
|
p = 0.0004
|
|
WCC
|
Cells/μl
|
6.5 (0-463; 100)
|
2 (0-16; 19)
|
p < 0.0002
|
|
WCC > 100/μl
|
Samples
|
13/101 (12.9%)
|
0/20 (0%)
|
p = n.s.
|
|
OCB
|
Samples
|
9/96 (9.4%)
|
2/20 (10%)
|
p = n.s.
|
|
QIgG > Qlim(IgG)
|
Samples
|
6/85 (7.1%)
|
1/18 (5.6%)
|
p = n.s.
|
|
QIgG
|
Ratio
|
3.47 (0.9-23.61; 84)
|
2.66 (1.47-6.7; 18)
|
p = n.s.
|
|
IgG-IF > 10%
|
Samples
|
4/84 (4.8%)
|
0/18 (0%)
|
p = n.s.
|
|
QIgM > Qlim(IgM)
|
Samples
|
11/73 (15.1%)
|
0/15 (0%)
|
p = n.s.
|
|
QIgM
|
Ratio
|
0.59 (0-13.81; 72)
|
0.3 (0-1.36; 15)
|
p < 0.03
|
|
QIgA > Qlim(IgA)
|
Samples
|
3/72 (4.2%)
|
1/15 (6.7%)
|
p = n.s.
|
|
QIgA
|
Ratio
|
1.76 (0-17.27; 71)
|
1.94 (0-4.83; 15)
|
p = n.s.
|
|
QAlb > Qlim(Alb)
|
Samples
|
42/88 (47.7%)
|
5/18 (27.8%)
|
p = n.s.
|
|
QAlb
|
Ratio
|
6.46 (2.98-32.67; 88)
|
5.55 (3.13-15.33; 18)
|
p = n.s.
|
|
CSF TP elevated
|
Samples
|
42/93 (45.2%)
|
5/20 (25%)
|
p = n.s.
|
|
CSF TP concentration
|
mg/dl
|
44.5 (20.5-176; 85)
|
36.65 (5.11-101; 18)
|
p = n.s.
|
|
CSF TP > 100 mg/dl
|
Samples
|
7/93 (7.5%)
|
1/20 (5%)
|
p = n.s.
|
|
CSF l-lactate elevated
|
Samples
|
16/65 (24.6%)
|
0/15 (0%)
|
p = 0.033
|
|
CSF l-lactate concentration
|
mg/dl
|
1.82 (1.05-4.43; 62)
|
1.7 (1.33-2.1; 14)
|
p = n.s.
|
|
CSF l-lactate > 3 mmol/l
|
Samples
|
4/65 (6.2%)
|
0/15 (0%)
|
p = n.s.
|
|
Time since attack onset
|
Days
|
8 (0-34; 104)
|
191 (117-2624; 20)
| |
- Ratios and concentrations are given as median (with ranges and sample numbers in brackets)
- IgG-IF intrathecal IgG fraction; OCB oligoclonal bands; QAlb CSF/serum albumin quotient; TP total protein
